StockVS

NYSE · Chemicals · USD

Braskem S.A. (BAK) Stock Analysis

Braskem S.A. (BAK) is a Chemicals stock listed on NYSE and quoted in US Dollar.

BAK

$1.89

−$0.05 (−2.58%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BAK with… →

BAK Key Statistics

As of Sep 4, 2026
Trading
Open
$1.94
Previous Close
$1.94
Day's Range
1.86–1.97
52-Week Range
1.40–5.40
Volume
888.70K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.68
Valuation
Market Cap
$753.14M
P/E Ratio
unprofitable
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.46
EPS (ttm)Profit attributable to each share over the last twelve months.
−2.70
Financials (FY)
Revenue (FY)
$70.72B−8.65%
Net Income (FY)
−$9.88B
Profit marginThe share of revenue left as profit after all costs and taxes.
−7.85%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
172.53M
1-Year Return
−44.57%
Dividend and dates
Earnings Date
November 12, 2026
Avg Volume
2.59M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

BAK Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−35.93%
2025−23.58%
2024−56.24%
2023−4.13%
2022−54.75%
2021+167.18%
2020−39.12%
2019−37.81%
2018−2.63%
2017+27.42%
2016 (partial year)+69.66%

As of September 4, 2026.

BAK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$70.72B−$9.88B−14.0%
2024$77.41B−$11.32B−14.6%
2023$70.57B−$4.58B−6.5%
2022$96.52B−$336.00M−0.3%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$70.72B$1.56B−$1.64B−$9.88B−14.0%
2024$77.41B$6.00B−$990.00M−$11.32B−14.6%
2023$70.57B$3.02B−$1.75B−$4.58B−6.5%
2022$96.52B$11.36B$6.11B−$336.00M−0.3%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BAK Valuation vs Chemicals Median

Median of 17 stocks
MetricBAKChemicals medianvs median
P/S ratio0.010.390.0x the median
Profit margin−7.85%−2.36%5.5 pts below

Medians across 17 Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Braskem S.A. (BAK) carries a market capitalisation of $753.14M. It is classified in the Chemicals industry, within the Basic Materials sector. Headcount on file is 8,233.

Over the past 52 weeks the price has ranged from $1.40 to $5.40. The most recent close on file for BAK is $1.89, dated September 4, 2026. That is −$0.05 (−2.58%) against the previous close. The latest close sits 35% above that 52-week low.

Financial Health

In fiscal 2025, Braskem S.A. reported revenue of $70.72B. That is −8.65% against the prior fiscal year, when revenue was $77.41B. The same year closed with a net loss of $9.88B. Profit margin runs at −7.85%. That is 5.5 percentage points below the Chemicals median of −2.36%. Trailing earnings per share are −2.7.

Across the 4 fiscal years on file, revenue moves from $96.52B in 2022 to $70.72B in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.46.

The reported beta is 0.68. Annualized volatility over the trailing 10 years is 60.06%. Over the trailing twelve months the price has returned −44.57%. Measured over 10 years, that is −16.11% a year compounded.

Growth & Income

The record shows no dividend for BAK.

Across the complete calendar years on file, 2021 returned +167.18% and 2024 returned −56.24%. Of the 9 complete calendar years on file, 2 finished higher. 2026 is still running; the price is −35.93% year to date.

Peer Comparison

Braskem S.A. (BAK) operates in the Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Braskem S.A. BAK $753.14M
Dow Inc. DOW $21.27B
Methanex Corporation MX.TO $6.28B 66.0
Celanese Corporation CE $4.90B

The Chemicals industry average P/E ratio is 13.3x. Braskem S.A. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Chemicals Stocks

View all Chemicals stocks →

Popular Basic Materials Stocks

View all Basic Materials stocks →

About Braskem S.A.

Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas. It also produces and sells polyethylene, including the production of green PE made from renewable resources, and polypropylene; and polyvinyl chloride and caustic soda. In addition, the company provides thermoplastic resins; and other basic petrochemicals. It has operations in the United States, Europe, Asia, and internationally. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil.

Visit website →